YOUNG BLACK PHARMA (EIN 861441033) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

MARISSA WEST

Phone

4698838523

Tax Period

2024-01-01 to 2024-12-31

YOUNG BLACK PHARMA, founded in 2021, is a small nonprofit in the Community Improvement sector that reported $877K in total revenue in fiscal year 2024. Revenue surged 126% from the prior year, signaling strong growth momentum. The organization ran a surplus of $283K, a strong 32% operating margin.

Mission

YBP's mission is to cultivate talent through mentoring initiatives that focus on the personal and professional development needed to excel in the pharmaceutical industry. To inspire pharmaceutical industry professionals to always strive for excellence inside and outside of their careers and prioritize paying it forward. To connect and network to share meaningful experiences and encourage community. Our vision is to empower professionals with essential resources and networking opportunities that improve the trajectory of professionals within the pharmaceutical industry.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $158,063

Program Service Revenue $719,078

Investment Income $0

Other Revenue $331

TOTAL REVENUE $877,472

Expense Breakdown

Grants Paid $50

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $0

Other Expenses $594,838

TOTAL EXPENSES $594,888

Year-over-Year Comparison

	2024	2023	Change
Revenue	$877,472	$389,049	+1.3%
Expenses	$594,888	$244,141	+1.4%
Net Income	$282,584	$144,908	+1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Ijeoma Oyetunde	Membership & Social Events Lead	10	Director	$0	$0	$0
Irene Okeke	2nd Vice President, Marketing Lead	10	Director	$0	$0	$0
Dawn Bey	1st Vice President, Professional Development Lead	10	Director	$0	$0	$0
Marissa West	President, Finance Lead	10	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$877,472	$594,888	$507,033	$282,584
2023	$389,049	$244,141	$171,642	$144,908

YOUNG BLACK PHARMA